4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-060380
President and CEO sold 142,409 shares at an average $16.95 ($2,413,729)
- President and CEO acquired 175,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Polymeropoulos Mihael Hristos · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-11 | Exercise or conversion : show line 1 in the form | +89,199 | $10.65 | $949,969 | 1,300,654 | D |
| 2019-12-11 | Sale : show line 2 in the form | −72,373 | $16.92 | $1,224,377 | 1,228,281 | D |
| 2019-12-12 | Exercise or conversion : show line 3 in the form | +85,801 | $10.65 | $913,781 | 1,314,082 | D |
| 2019-12-12 | Sale : show line 4 in the form | −70,036 | $16.98 | $1,189,351 | 1,244,046 | D |
| Open-market sales · 142,409 sh · avg $16.95 · $2,413,729 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-12-11 | Exercise or conversion : show line 5 in the form Employee Stock Option (Right to Buy) | −89,199 | 85,801 | D |
| 2019-12-12 | Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) | −85,801 | 0 | D |
Loading xslF345X03/doc4.xml…